|
LEXX | Lexaria Bioscience Corp. |
|
|
LEXX | Lexaria Bioscience Corp. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.64 |
| Leverage | 25.24% |
| Market Cap | $ 7.1m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -10.8m |
| Margin | -2210.21% |
Lexaria Bioscience Corp. The company is headquartered in Kelowna, Canada.